Aeovian Pharmaceuticals

Aeovian Pharmaceuticals Inc.

Berkeley, United States · Founded 2012 · $142.0M raised

Employees
11–50
Founded
2012
Business Model
B2B
Total Funding
$142.0M
Last Round
$55.0M Series BDec 2025
Rounds
3

About

Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted and highly selective small molecules to restore cellular metabolic quality control. These candidates address the dysregulated growth and hyperactive signaling found in certain rare genetic and age-related diseases. The company is focused on improving treatments in areas such as seizures, where existing mTOR inhibitors can have efficacy but also significant safety limitations.

Summary

Aeovian Pharmaceuticals is a Biotech company based in Berkeley, United States, founded in 2012. It has raised $142.0M in total across 3 rounds, most recently a $55.0M Series B round in Dec 2025. Investors include LUMA.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BDec 2025
$55.0M

Sign up to see all 3 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aeovian Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/aeovian-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/aeovian-pharmaceuticals" alt="Aeovian Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>